On this page
With new Australian consensus recommendations and available therapies for heart failure with reduced ejection fraction (HFrEF), GPs now have further options for optimising management of their HFrEF patients. Listen to Dr Chee Khoo discuss the updated recommendations and its implications for clinical practice, in both current and newly diagnosed patients.
Questions asked in the video
- What is the new universal definition of heart failure? 0:00
- What key symptoms and signs should be considered when screening for HFrEF? 1:51
- What updates have occurred after the Australian heart failure guidelines of 2018? 3:25
- What are the "four pillars of HFrEF management"? 5:10
- How does this inform medication use in HFrEF? 6:11
- What are some key points for titrating first-line medications for HFrEF? 7:13
- What follow-up is recommended for HFrEF patients after commencing treatment? 8:31
This module is supported by an independent medical education grant from Boehringer Ingelheim and Eli Lilly Alliance.
Sponsored by